Novavax COVID-19 Vaccine (recombinant, adjuvanted)

Global information about the Nuvaxovid XBB.1.5 COVID-19 Vaccine (recombinant, adjuvanted) and Novavax COVID-19 Vaccine (recombinant, adjuvanted)

The approval status of the Nuvaxovid XBB.1.5 COVID-19 Vaccine (recombinant, adjuvanted) and Novavax COVID-19 Vaccine (recombinant, adjuvanted) varies worldwide. In countries where the vaccine has not been approved or authorized by the relevant regulatory authority or regulatory process, you will not find information about it on this site. This site will be updated as more information becomes available.

Please answer the questions below.